• Skip to main content

Parkinson’s Treatment Report

www.ParkinsonsTreatmentReport.com

simvastatin

Simvastatin as a Neuroprotective Treatment for Moderate Parkinson’s Disease

June 1, 2020

https://clinicaltrials.gov/ct2/show/NCT02787590?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F18%2F2020&lupd_d=14&sort=nwst

STUDY TITLE:
Simvastatin as a Neuroprotective Treatment for Moderate Parkinson’s Disease

DESCRIPTION:
Condition:   Parkinson Disease
Interventions:   Drug: Simvastatin;   Drug: Matched Placebo (for Simvastatin)
Sponsors:   University Hospital Plymouth NHS Trust;   University of Plymouth
Active, not recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT02787590

FIRST POSTED:
Wed, 01 Jun 2016 12:00:00 EDT

LAST UPDATE POSTED:
06/01/20 07:10AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02787590?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F18%2F2020&lupd_d=14&sort=nwst

Powered by Urgent Research

Copyright © 2025 Urgent Research